Virginia Jean Homewood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3336 S 4155 W, Ste 301, Salt Lake City, UT 84120 Phone: 801-964-3865 Fax: 801-964-3894 |
Alexandra L. Woodcock, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-213-3716 |
Lillian B. Boettcher, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 |
Patricia Bearnson, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4465 S 900 E Ste 275, Salt Lake City, UT 84124 Phone: 801-272-6100 Fax: 801-272-6101 |
Eric C Nielson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1220 East 3900 South, Suite 3e, Salt Lake City, UT 84124 Phone: 801-685-7188 Fax: 801-685-8116 |
Susan T Horvath, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1140 E 3900 S Ste 400, Salt Lake City, UT 84124 Phone: 801-262-8666 Fax: 801-263-8821 |
Carolyn Weaver Swenson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2995 |
Morgan A. Scaglione, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-581-5501 |
Dr. Jonathan Pearson Daniels, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 82 S 1100 E Ste 305, Salt Lake City, UT 84102 Phone: 801-214-7650 Fax: 801-214-7650 |
Kiera N. Sibbald, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Helix: 30 N Mario Capecchi Dr 5s146, Salt Lake City, UT 84112 Phone: 801-581-2121 |
Dr. Jessica Marie Page, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-8425 |
Kaitlyn P. Casper, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-581-5501 |
Lois Jeanne Gemmell, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 455 E South Temple, #202, Salt Lake City, UT 84111 Phone: 801-355-9951 Fax: 801-355-9968 |
Dr. Peggy A. Norton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-3565 Fax: 801-587-8431 |
Kathryn S. Brown, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Ste 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 |
Karen L. Miller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 555 Foothill Dr, Salt Lake City, UT 84112 Phone: 801-581-8995 |
Dr. Hannele Marie Laine, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 455 E South Temple, Suite #202, Salt Lake City, UT 84111 Phone: 801-355-9951 Fax: 801-355-9968 |
Dr. Shannon L Tilly, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1525 W 2100 S, Salt Lake City, UT 84119 Phone: 801-213-9900 |
Allyson Marie Servoss, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 389 S 900 E, Salt Lake City, UT 84102 Phone: 385-282-2000 |
Susan E. Dalton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 |
News Archive
Prime Healthcare Services announced today that it has purchased Dallas Medical Center, located in Dallas, Texas.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 6 days ago